Shantou Institute of Ultrasonic Instrument
301602
Hubei Sinophorus Electronic Materials
688545
Pansoft
300996
4
Jiayu Holding
300117
5
Wuxi Taclink Optoelectronics Technology
688205
US Stock MarketDetailed Quotes
LGVN Longeveron
- 1.741
- -0.029-1.66%
Trading Jan 22 12:43 ET
25.83MMarket Cap-0.31P/E (TTM)
1.830High1.720Low78.75KVolume1.820Open1.770Pre Close139.86KTurnover0.67%Turnover RatioLossP/E (Static)14.84MShares7.90652wk High1.01P/B20.33MFloat Cap0.77152wk Low--Dividend TTM11.68MShs Float450.000Historical High--Div YieldTTM6.22%Amplitude0.770Historical Low1.776Avg Price1Lot Size
About Longeveron Company
Longeveron, Inc. is a clinical stage biotechnology company, which engages in the development of cellular therapies for specific aging-related and life-threatening conditions. Its lead product, LOMECEL-B, is a cell-based therapy product, which is derived from culture-expanded medicinal signaling cells that are sourced from bone marrow of young, healthy, adult donors. The company was founded by Joshua M. Hare and Donald M. Soffer on October 9, 2014 and is headquartered in Miami, FL.
Company Profile
SymbolLGVN
Company NameLongeveron
Listing DateFeb 12, 2021
Issue Price10.00
Founded2014
CEOMr. Mohamed Wael Ahmed Hashad
MarketNASDAQ
Employees25
Fiscal Year Ends12-31
AddressLife Science & Technology Park,1951 Northwest 7th Avenue,Suite 250
CityMiami
ProvinceFlorida
CountryUnited States of America
Zip Code33136
Phone1-305-909-0840
Websitehttp://www.longeveron.com
Company Executives
- Name
- Position
- Salary
- Mohamed Wael Ahmed Hashad
- Chief Executive Officer and Director
- 1.58M
- Dr. Joshua M. Hare, M.D.
- Chief Science Officer and Chairman of the Board
- 75.31K
- Lisa Locklear
- Treasurer, Chief Financial Officer and Principal Accounting Officer
- 380.78K
- Dr. Nataliya Agafonova
- Chief Medical Officer
- --
- Lisa McClain-Moss
- Vice President, Manufacturing
- --
- Dr. Roger Hajjar
- Director
- --
- Neha Motwani
- Director
- --
- Rock Soffer
- Director
- 43.81K
- Neil E. Hare
- Director
- 40.31K
- Richard N. Kender, M.B.A.
- Independent Director
- --
- Ursula Ungaro
- Independent Director
- 50.81K
- Khoso Baluch
- Independent Director
- 35.97K
- Paul Lehr
- General Counsel and Secretary
- 554.06K
Trending Stocks
Investment Course
Top 5 Industries for Stock Trading under Trump's Second Term
Stocks & Industries to Watch Under Trump's Second Presidency
With mooomoo, find out which stocks and industries may benefit from Trump's second presidency, based on his first administration's track record.
Stocks & Industries to Watch Under Trump's Second Presidency
Key takeaways Tech stocks underwent substantial growth due to tax cuts and reduced corporate regulations in Trump's first term along with defense and aerospace
Discussing
December CPI comes in as expected, is that enough?
U.S. December CPI rose 2.9% year-on-year, aligning with expectations but marking a three-month inflation increase trend. The market reacted
In One Chart
Jan 15 22:05
Here's the Breakdown for December CPI, in One Chart